Northwest Bioth Cmn (NWBO)

$0.26 +0.00 (1.65%)
Market Cap 405.51M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 1,867,600
Avg Vol 3,407,590
Day's Range N/A - N/A
Shares Out 1.59B
Stochastic %K 28%
Beta -0.86
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable sol...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
Ablidy
Ablidy Sep. 16 at 10:21 AM
$NWBO
1 · Reply
Ablidy
Ablidy Sep. 16 at 10:20 AM
$NWBO why $NWBO is at the top of rebooted immune system …..Anyone following Braelyn’s treatment in UK ? how fast memory T cells took hold ? What is important https://x.com/stemcelltracker/status/2100158754306093384?s=12 Follow and read Caravello on twitter
0 · Reply
ILuvbiotech
ILuvbiotech Sep. 16 at 9:57 AM
$NWBO Braelyn story still trending on X , hopefully this puts pressure on the Mhra and makes the fda in the US aware of it
1 · Reply
kidder750
kidder750 Sep. 16 at 7:56 AM
$NWBO people. The silent partner is NWBO. Dr Jenkins is also on the board of directors of ORI BIOTECH. Do your DD. Look what her job is at NWBO and look at the collaboration of the partnership. She is doing what she was hired to do by NWBO and she also is on the board of directors of ORI BIOTECH.
1 · Reply
Paffus
Paffus Sep. 16 at 7:49 AM
$NWBO Come on and Lfg🦬💎🦍
0 · Reply
Wilma_Dicfit
Wilma_Dicfit Sep. 16 at 6:09 AM
$NWBO social media frenzy resulted in 3 donations to the go fund me campaign totalling $115 Thats the power of news.
0 · Reply
Surforever
Surforever Sep. 16 at 5:01 AM
$NWBO Interesting AI food for thought: If NWBO received UK commercial approval before November 14, the SNO presentation would occur in a very different context: UK approval → SNO presentation → DCVax-L + PD-1 data That could give investors, physicians and potential partners three separate pieces of information in relatively close proximity: Regulatory validation: DCVax-L has actually obtained commercial authorization in the UK. Updated DCVax-L evidence: NWBO has already presented the 2026 patient-level analyses suggesting the original survival benefit may have been underestimated. Combination/biological evidence: the UCLA presentation addresses whether sequencing PD-1 blockade with dendritic-cell vaccination affects T-cell responses and survival in recurrent GBM. That combination could make SNO more consequential than if the presentation occurred while DCVax-L was still only awaiting its first commercial approval. Hmmmmm...
2 · Reply
None_
None_ Sep. 16 at 2:58 AM
$NWBO @wjmax D_stock strikes again! The speculation 100% delusional!
0 · Reply
None_
None_ Sep. 16 at 2:54 AM
$NWBO https://www.modernatx.com/research/product-pipeline
0 · Reply
None_
None_ Sep. 16 at 2:52 AM
$NWBO
1 · Reply
Latest News on NWBO
No data available.
Ablidy
Ablidy Sep. 16 at 10:21 AM
$NWBO
1 · Reply
Ablidy
Ablidy Sep. 16 at 10:20 AM
$NWBO why $NWBO is at the top of rebooted immune system …..Anyone following Braelyn’s treatment in UK ? how fast memory T cells took hold ? What is important https://x.com/stemcelltracker/status/2100158754306093384?s=12 Follow and read Caravello on twitter
0 · Reply
ILuvbiotech
ILuvbiotech Sep. 16 at 9:57 AM
$NWBO Braelyn story still trending on X , hopefully this puts pressure on the Mhra and makes the fda in the US aware of it
1 · Reply
kidder750
kidder750 Sep. 16 at 7:56 AM
$NWBO people. The silent partner is NWBO. Dr Jenkins is also on the board of directors of ORI BIOTECH. Do your DD. Look what her job is at NWBO and look at the collaboration of the partnership. She is doing what she was hired to do by NWBO and she also is on the board of directors of ORI BIOTECH.
1 · Reply
Paffus
Paffus Sep. 16 at 7:49 AM
$NWBO Come on and Lfg🦬💎🦍
0 · Reply
Wilma_Dicfit
Wilma_Dicfit Sep. 16 at 6:09 AM
$NWBO social media frenzy resulted in 3 donations to the go fund me campaign totalling $115 Thats the power of news.
0 · Reply
Surforever
Surforever Sep. 16 at 5:01 AM
$NWBO Interesting AI food for thought: If NWBO received UK commercial approval before November 14, the SNO presentation would occur in a very different context: UK approval → SNO presentation → DCVax-L + PD-1 data That could give investors, physicians and potential partners three separate pieces of information in relatively close proximity: Regulatory validation: DCVax-L has actually obtained commercial authorization in the UK. Updated DCVax-L evidence: NWBO has already presented the 2026 patient-level analyses suggesting the original survival benefit may have been underestimated. Combination/biological evidence: the UCLA presentation addresses whether sequencing PD-1 blockade with dendritic-cell vaccination affects T-cell responses and survival in recurrent GBM. That combination could make SNO more consequential than if the presentation occurred while DCVax-L was still only awaiting its first commercial approval. Hmmmmm...
2 · Reply
None_
None_ Sep. 16 at 2:58 AM
$NWBO @wjmax D_stock strikes again! The speculation 100% delusional!
0 · Reply
None_
None_ Sep. 16 at 2:54 AM
$NWBO https://www.modernatx.com/research/product-pipeline
0 · Reply
None_
None_ Sep. 16 at 2:52 AM
$NWBO
1 · Reply
None_
None_ Sep. 16 at 2:49 AM
$NWBO ''Meanwhile, Jefferies analysts offered their own take last month, suggesting that an RFS hazard ratio between 0.5 and 0.8 “should be meaningful,” with positive results likely boding well for intismeran’s slew of other ongoing phase 2 and 3 trials in a variety of solid tumors.'' https://www.fiercebiotech.com/biotech/merck-and-modernas-personalized-cancer-vaccine-slows-recurrence-ph-3-trial
0 · Reply
None_
None_ Sep. 16 at 2:49 AM
$NWBO ''In the meantime, the companies said they plan to present the trial data at an upcoming international medical meeting, as well as “engage with regulators on filing submissions for intismeran autogene in combination with Keytruda.” Speaking to investors during a second quarter earnings call last month, Moderna President Stephen Hoge, M.D., said that a positive interim readout “would obviously make the case for an accelerated review.”'' https://www.fiercebiotech.com/biotech/merck-and-modernas-personalized-cancer-vaccine-slows-recurrence-ph-3-trial
0 · Reply
wjmax
wjmax Sep. 16 at 2:45 AM
$NWBO Maybe Lifera can acquire a certain percentage of 900m shares at a specific price that LP will be happy about. For example, 100m share with $100 per share.
1 · Reply
None_
None_ Sep. 16 at 2:43 AM
$NWBO DCVax is an expensive placebo. No collaborations between the two either.
0 · Reply
Cocacola1971
Cocacola1971 Sep. 16 at 2:18 AM
$NWBO so I’m just gonna throw this out. Nothing scientific about this just a gut feeling. I think the most logical company to either buy us out or take a big stake in the company would be Merck. Market cap 354 billion. Shares outstanding 2.47 billion. From what I’ve seen we’ve kind of worked with them on and off collaborating. They could take a stake in the company or do half cash half stock. Or even more stock and less cash, depending on what they have in reserves. Haven’t checked their balance sheets so maybe it’s a moot point.
1 · Reply
YoshiVol
YoshiVol Sep. 16 at 2:06 AM
$NWBO it’s clear we have gone viral!! if D.C. VAX was a female… It would be called Sydney Sweeney!!!!! Holla!
5 · Reply
None_
None_ Sep. 16 at 1:21 AM
$NWBO @wjmax ''D_stock strikes again: Posted ORI and NWBO were connected with ORIs recent announcement and $120M partnership with a undisclosed company. Once again, this poster was COMPLETELY wrong and the speculation 100% delusional. Come to find out ORIs $120M partner was a company with a already approved drug. You are being counter productive and misleading.''
0 · Reply
Tornadowarning0304
Tornadowarning0304 Sep. 16 at 12:06 AM
$NWBO retail, this is shaping into Andrew Left 2.0 (Anson funds) took the deal an snitched on Left an now Candace’s took the deal an gave damaging info ℹ️ data 📉 to NWBO on how they all did it, so tomorrow is the beginning on who’s lying 🤥 an that’s why the crooks trying to seal 🦭 it but let’s pray 🙏 that Judge 🧑‍⚖️ Stein say no like before he said no dismissal to these crooks he also see a pattern of their crooked algo
3 · Reply
Tornadowarning0304
Tornadowarning0304 Sep. 16 at 12:01 AM
$NWBO retail, don’t focus 🧘‍♀️ in what shills an wolves 🐺 in sheep 🐑 clothing are saying, tomorrow will show these scumbags crooks no more it’s discovery 💡 phase an citadel/virtu already said it wasn’t them but the HFs not our algo, we will find out tomorrow why citadel-virtu an minions threw HFs under the bus 🚌, an remember Caanacord gave NWBO data 📉 on their shared algo
1 · Reply
DaMan911
DaMan911 Sep. 15 at 11:23 PM
$NWBO Ori Biotech's Ori Biotech AMT Announcement IRO platform received an Advanced Manufacturing Technology (AMT) designation from the U.S. Food and Drug Administration (FDA) in September 2025, rather than a standard commercial product approval. What is the AMT Designation? • It is a special recognition program created by the FDA. • It encourages the use of innovative tools that improve manufacturing for critical medical therapies. • It validates that the IRO system can help boost supplies and cut development timelines. Benefits for Developers • Developers using the Ori Biotech Partnership Details system get earlier and more frequent communication with the FDA. • It reduces regulatory uncertainty during the review process. • It creates a clearer and faster path from early research to commercial launch. Would you like to know more about how the IRO platform automates cell and gene therapy manufacturing? AI responses may include mistakes.
0 · Reply
Tornadowarning0304
Tornadowarning0304 Sep. 15 at 10:31 PM
$NWBO anyone talking about the vaccine is a scumbag shill an skunk, who don’t want any vaccine for cancer only a rat 🐀 an skunk🦨 an speaking of rats 🐀 citadel -virtu an their minions snitched on HFs lol 😂 saying it wasn’t them, but the good 👍 part is they have to give those HFs up 🆙 an here’s the best part citadel -virtu an the other crooks don’t know what data 📈 Caanacord gave them it had to be a lot 😂 so now tomorrow in court those rats 🐀 an dirty rats 🐀 becomes the 3blind mice 🐁 (no pun intended)
2 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Sep. 15 at 9:56 PM
$NWBO the pumping bots are out hard the last week.. bad news is on the horizon📉📉📉📉
1 · Reply